Guided Therapeutics (GTHP) Shares Outstanding (Weighted Average) (2010 - 2025)
Guided Therapeutics recorded quarterly Shares Outstanding (Weighted Average) of $78.4 million in Q4 2025, up 2.7% quarter-over-quarter from $76.4 million in Q3 2025, and up 36.76% year-over-year from $57.3 million in Q4 2024.
Guided Therapeutics' Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $78.4 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Weighted Average) rose 36.76% year-over-year to $78.4 million; the TTM figure through Dec 2025 stood at $78.4 million (up 36.76% YoY), while the FY2025 annual figure was $78.4 million, up 36.76% from the prior year.
- Shares Outstanding (Weighted Average) came in at $78.4 million for Q4 2025 at Guided Therapeutics, up from $76.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $78.4 million in Q4 2025 to a low of $49297.0 in Q1 2023.
- A 5-year average of $39.4 million and a median of $32.4 million in 2022 frame the typical range for Shares Outstanding (Weighted Average).
- Across the five-year window, Shares Outstanding (Weighted Average) surged 262656.83% in 2021 and sank 99.76% in 2023, its largest moves.
- Guided Therapeutics' Shares Outstanding (Weighted Average) stood at $13.4 million in 2021, then jumped by 166.03% to $35.6 million in 2022, then declined by 19.68% to $28.6 million in 2023, then surged by 100.59% to $57.3 million in 2024, then jumped by 36.76% to $78.4 million in 2025.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $78.4 million, $76.4 million, and $73.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 78.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 78.41 Mn |
| Sep 30, 2025 | 76.35 Mn |
| Jun 30, 2025 | 73.59 Mn |
| Mar 31, 2025 | 68.29 Mn |
| Dec 31, 2024 | 57.34 Mn |
| Sep 30, 2024 | 55.93 Mn |
| Jun 30, 2024 | 55.99 Mn |
| Mar 31, 2024 | 29.29 Mn |
| Dec 31, 2023 | 28.58 Mn |
| Sep 30, 2023 | 50.59 Mn |
| Jun 30, 2023 | 50.97 Mn |
| Mar 31, 2023 | 49,297.00 |
| Dec 31, 2022 | 35.59 Mn |
| Sep 30, 2022 | 27.34 Mn |
| Jun 30, 2022 | 26.34 Mn |
| Mar 31, 2022 | 20.68 Mn |
| Dec 31, 2021 | 13.38 Mn |
| Sep 30, 2021 | 13.42 Mn |
| Jun 30, 2021 | 13.23 Mn |
| Mar 31, 2021 | 13.17 Mn |
| Dec 31, 2020 | 10.77 Mn |
| Sep 30, 2020 | 9,985.00 |
| Jun 30, 2020 | 11,913.00 |
| Mar 31, 2020 | 5,013.00 |
| Dec 31, 2019 | 7.50 Mn |
| Sep 30, 2019 | 3,319.00 |
| Jun 30, 2019 | 3,284.00 |
| Mar 31, 2019 | 3,248.00 |
| Dec 31, 2018 | 462.00 |
| Sep 30, 2018 | 252.00 |
| Jun 30, 2018 | 179.00 |
| Mar 31, 2018 | 111.00 |
| Dec 31, 2017 | 11.00 |
| Sep 30, 2017 | 2,632.00 |
| Jun 30, 2017 | 1,434.00 |
| Mar 31, 2017 | 946.00 |
| Dec 31, 2016 | 203.00 |
| Sep 30, 2016 | 114.00 |
| Jun 30, 2016 | 22.00 |
| Mar 31, 2016 | 39.00 |
| Dec 31, 2015 | 2.00 |
| Sep 30, 2015 | 1.00 |
| Jun 30, 2015 | 102,326.00 |
| Mar 31, 2015 | 973.00 |
| Dec 31, 2014 | 771.00 |
| Sep 30, 2014 | 77,651.00 |
| Jun 30, 2014 | 72,223.00 |
| Mar 31, 2014 | 71,451.00 |
| Dec 31, 2013 | 65,884.00 |
| Sep 30, 2013 | 65,212.00 |
| Jun 30, 2013 | 65,675.00 |
| Mar 31, 2013 | 63,671.00 |
| Dec 31, 2012 | 57,429.00 |
| Sep 30, 2012 | 60,827.00 |
| Jun 30, 2012 | 53,274.00 |
| Mar 31, 2012 | 52,471.00 |
| Dec 31, 2011 | 48,868.00 |
| Sep 30, 2011 | 48,379.00 |
| Jun 30, 2011 | 48,464.00 |
| Mar 31, 2011 | 47,851.00 |
| Dec 31, 2010 | 38,596.00 |
| Jun 30, 2010 | 32,520.00 |